Synolo Therapeutics
Synolo Therapeutics is advancing a new class of therapeutics for cancer. Launched by RA Ventures* and leveraging a proprietary discovery platform, we are rapidly building a pipeline of differentiated conditionally-active immunotherapies which promise to be highly effective and safer than the current standard of care.*RA Ventures is the venture focused division of RA Capital Management.
7-day free trial · no credit card
Verified contacts
12
available on Kipplo
LinkedIn employees
18
1 to 10 range
Open roles
—
no listings
Distinct roles
6
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 12 verified contacts at Synolo Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
12 contacts with verified email or phone · masked until revealed.
- GS
Gairik Sachdeva
Vice President of Business and Corporate Development · General Business & Management
EmailPhone - AS
Anish Suri
() · Other
EmailPhone - RD
Roy Dornbrook
,, · Other
EmailPhone
Showing 3 of 12 verified contacts
Top roles at Synolo Therapeutics
6 distinct titles indexed · top 6 shown.
- 2director, immunology
- 1()
- 1,,
- 1senior research associate
- 1senior scientist
- 1vice president of business and corporate development
Sign up to unlock all 12 contacts at Synolo Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 12 verified contacts at Synolo Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.